Overcoming drug resistance by harnessing mitochondrial divisome for treating cholangiocarcinoma

IF 26.8 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Journal of Hepatology Pub Date : 2025-05-09 DOI:10.1016/j.jhep.2025.04.038

Mengwei Niu, Wen-Xing Ding

引用次数: 0

Abstract

Section snippets

Competing interests

The authors declare no conflicts of interest that pertain to this work.Please refer to the accompanying ICMJE disclosure forms for further details.

Authors’ contributions

M.W & WXD conceived and wrote the manuscript.

Data Availability Statement:

There are no data associated with this study.

Financial support

This study was supported in part by the National Institute of Health (NIH) funds R37 AA020518, R21 AA030617 and R01AA031230 (WXD).

查看原文本刊更多论文

利用线粒体分裂体治疗胆管癌克服耐药性

利益冲突作者声明本工作不存在利益冲突。详情请参阅随附的ICMJE披露表格。作者的contributionsM。W,WXD构思并撰写了手稿。数据可用性声明：没有与本研究相关的数据。本研究由美国国立卫生研究院（NIH）基金R37 AA020518， R21 AA030617和R01AA031230 （WXD）部分支持。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Hepatology 医学-胃肠肝病学

CiteScore

46.10

自引率

4.30%

发文量

2325

审稿时长

30 days

期刊介绍： The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.